InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, will present virtually at the 39 th Annual J.P. Morgan Healthcare Conference being held January 11-14, 2021. Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, will give a corporate presentation on Thursday, January 14 th at 7:30 am EST (1:30 pm CET) . A live audio w
January 7, 2021
· 3 min read